WEBVTT - Getting Yeast to Make Medicine

0:00:15.356 --> 0:00:22.916
<v Speaker 1>Pushkin. There's this problem that's been going on in the

0:00:22.956 --> 0:00:26.276
<v Speaker 1>background in the United States for a long time. The

0:00:26.316 --> 0:00:31.996
<v Speaker 1>problem is this, there are not enough drugs to go around. This, strangely,

0:00:32.436 --> 0:00:35.436
<v Speaker 1>is not about expensive new drugs that people can't afford.

0:00:35.876 --> 0:00:39.836
<v Speaker 1>This is about old, cheap generic drugs, drugs that just

0:00:39.916 --> 0:00:43.436
<v Speaker 1>are not available in sufficient quantities at any price. A

0:00:43.516 --> 0:00:47.756
<v Speaker 1>national pharmacist group recently reported shortages of three hundred and

0:00:47.956 --> 0:00:52.316
<v Speaker 1>nine of these generic drugs. There are multiple causes. It

0:00:52.356 --> 0:00:55.596
<v Speaker 1>could be the bankruptcy of some little known generic drug maker.

0:00:55.876 --> 0:00:58.956
<v Speaker 1>Could be a sudden surge in demand. Could be the

0:00:58.956 --> 0:01:01.916
<v Speaker 1>failure of some distant crop that is the source of

0:01:01.956 --> 0:01:06.276
<v Speaker 1>an essential drug ingredient. It's a complicated problem built out

0:01:06.316 --> 0:01:09.916
<v Speaker 1>of lots of little problems. But broadly speaking, the supply

0:01:10.076 --> 0:01:14.036
<v Speaker 1>chain for generic drugs is long and opaque and exists

0:01:14.156 --> 0:01:17.356
<v Speaker 1>largely outside of the United States, so it is very

0:01:17.396 --> 0:01:25.676
<v Speaker 1>difficult to see these drug shortages coming. I'm Jacob Goldstein

0:01:25.756 --> 0:01:27.716
<v Speaker 1>and this is What's Your Problem, the show where I

0:01:27.796 --> 0:01:30.836
<v Speaker 1>talk to people who are trying to make technological progress.

0:01:31.396 --> 0:01:34.756
<v Speaker 1>My guest today is Christina Smolky. She's a professor at

0:01:34.796 --> 0:01:37.956
<v Speaker 1>Stanford and the co founder and CEO of a company

0:01:37.956 --> 0:01:41.356
<v Speaker 1>called Anthea. It's a synthetic biology company. They're in the

0:01:41.396 --> 0:01:47.356
<v Speaker 1>business of genetically engineering microorganisms to produce commercial products. Christina's

0:01:47.396 --> 0:01:50.596
<v Speaker 1>problem is this, how do you turn ye cells into

0:01:50.676 --> 0:01:55.756
<v Speaker 1>tiny factories to create the active ingredients in drugs. If

0:01:55.836 --> 0:01:58.956
<v Speaker 1>Christina and her colleagues solve this problem, they won't solve

0:01:58.996 --> 0:02:02.156
<v Speaker 1>the drug shortage problem entirely, but they might help make

0:02:02.196 --> 0:02:02.676
<v Speaker 1>it better.

0:02:05.596 --> 0:02:08.516
<v Speaker 2>I actually started not in industry, not as a CEO

0:02:08.556 --> 0:02:10.716
<v Speaker 2>of a company, but I started as a professor. And

0:02:10.756 --> 0:02:13.236
<v Speaker 2>so there, you know, I was coming out the field

0:02:13.516 --> 0:02:16.076
<v Speaker 2>in a more academic way, looking at here's the state

0:02:16.076 --> 0:02:18.716
<v Speaker 2>of the technology, but think about how much more we

0:02:18.716 --> 0:02:21.436
<v Speaker 2>could do if we really open this up. And so,

0:02:21.636 --> 0:02:23.756
<v Speaker 2>you know, it was really let's focus on the hard problems.

0:02:23.836 --> 0:02:26.196
<v Speaker 2>Let's focus on the problems that people say right now

0:02:26.236 --> 0:02:28.676
<v Speaker 2>are impossible, that you will never get this to work,

0:02:28.876 --> 0:02:31.596
<v Speaker 2>the science just can't do it. And let's figure out

0:02:31.716 --> 0:02:36.316
<v Speaker 2>can we actually you know, make these impossible solutions possible

0:02:36.356 --> 0:02:38.556
<v Speaker 2>to really address these problems. And so that's where it started.

0:02:38.636 --> 0:02:40.796
<v Speaker 2>You know, for about fifteen years of my career was

0:02:40.876 --> 0:02:45.796
<v Speaker 2>really focusing on the you know, foundational scientific breakthroughs that

0:02:45.836 --> 0:02:48.476
<v Speaker 2>were needed to build a company like Anthea and really

0:02:48.796 --> 0:02:51.076
<v Speaker 2>bring those transformations into the industry.

0:02:51.476 --> 0:02:54.476
<v Speaker 1>So when you when you're starting out, you're thinking, Okay,

0:02:54.516 --> 0:02:58.036
<v Speaker 1>there is this nascent field synthetic biology, this basic idea,

0:02:58.796 --> 0:03:01.076
<v Speaker 1>I want to advance this field to the point where

0:03:01.076 --> 0:03:03.556
<v Speaker 1>we can make you know, drugs or the active ingredient

0:03:03.556 --> 0:03:05.916
<v Speaker 1>in drugs exactly what are the things people didn't know

0:03:05.956 --> 0:03:07.956
<v Speaker 1>how to do that you and your colleagues had to

0:03:07.956 --> 0:03:08.396
<v Speaker 1>figure out.

0:03:09.356 --> 0:03:12.236
<v Speaker 2>So there was a lot to figure out. And you know,

0:03:12.276 --> 0:03:14.236
<v Speaker 2>first and foremost when you looked at where the field

0:03:14.396 --> 0:03:17.676
<v Speaker 2>was when we when I started in this space, most

0:03:17.716 --> 0:03:20.436
<v Speaker 2>of where everybody focused and it's actually true still today

0:03:20.876 --> 0:03:25.516
<v Speaker 2>is on engineering cells to produce relatively simple compounds. So

0:03:25.596 --> 0:03:26.996
<v Speaker 2>let's just take a step back, and you know, we

0:03:27.116 --> 0:03:31.076
<v Speaker 2>use yeast, very similar organism that yeah, basically identical organism

0:03:31.116 --> 0:03:34.836
<v Speaker 2>that we've been using for centuries to brew beer, ferment wine, right,

0:03:35.076 --> 0:03:38.036
<v Speaker 2>so we have a long standing history of that. That's biomanufacturing.

0:03:38.436 --> 0:03:42.476
<v Speaker 2>But what the yeast of producing is ethanol, right, carbon dioxide,

0:03:42.596 --> 0:03:46.556
<v Speaker 2>very simple molecules that it does naturally. Now take a

0:03:46.556 --> 0:03:49.836
<v Speaker 2>step back, we want that yeast to produce a very

0:03:49.836 --> 0:03:55.076
<v Speaker 2>complex chemotherapeutic, right, or a very complex anti infective. How

0:03:55.116 --> 0:03:57.196
<v Speaker 2>do we teach it to do that? And when you

0:03:57.236 --> 0:03:59.396
<v Speaker 2>looked at where we started, you know, in this in

0:03:59.476 --> 0:04:02.356
<v Speaker 2>this field, what the field was capable of doing was

0:04:02.356 --> 0:04:06.036
<v Speaker 2>basically taking a organism like yeast and maybe moving you know,

0:04:06.196 --> 0:04:10.876
<v Speaker 2>three genes or three proteins into that organism. That basically

0:04:10.956 --> 0:04:14.436
<v Speaker 2>allowed the industry to produce very simple compounds.

0:04:13.916 --> 0:04:16.076
<v Speaker 1>Perfume, right. I feel like perfume was one of the

0:04:16.076 --> 0:04:17.596
<v Speaker 1>big ones, sense exactly.

0:04:17.636 --> 0:04:20.316
<v Speaker 2>Very close in structure to what the yeast could already make. Right,

0:04:20.956 --> 0:04:25.356
<v Speaker 2>in order to actually make these you know, drug ingredients,

0:04:25.596 --> 0:04:27.676
<v Speaker 2>we had to be able to transform the field from

0:04:27.676 --> 0:04:30.196
<v Speaker 2>thinking about and being able to sort of routinely move

0:04:30.236 --> 0:04:33.916
<v Speaker 2>maybe three to six genes or protein coding sequences into

0:04:33.916 --> 0:04:37.836
<v Speaker 2>the cell to be able to actually move twenty thirty

0:04:37.956 --> 0:04:41.396
<v Speaker 2>or more genes and protein sequences into a cell. And again,

0:04:41.516 --> 0:04:44.556
<v Speaker 2>these drug ingredients that we rely on are so you know,

0:04:44.556 --> 0:04:46.916
<v Speaker 2>they're so different, and they're so complicated from what yeast

0:04:46.916 --> 0:04:47.676
<v Speaker 2>would normally make.

0:04:47.916 --> 0:04:52.436
<v Speaker 1>Yes, it was not built to make chemotherapy drugs, right,

0:04:52.756 --> 0:04:56.396
<v Speaker 1>to spend a billion years evolving to make the drugs

0:04:56.436 --> 0:04:58.996
<v Speaker 1>we need to cure cancer exactly. So it is the

0:04:59.116 --> 0:05:01.116
<v Speaker 1>basic problem that like if you try and swap in

0:05:01.196 --> 0:05:04.276
<v Speaker 1>that many genes at once, the cell will just kind

0:05:04.316 --> 0:05:06.196
<v Speaker 1>of blow up and die. Be like, what are you

0:05:06.236 --> 0:05:08.716
<v Speaker 1>doing to me? I mean it's that the basic starting problem.

0:05:08.796 --> 0:05:10.676
<v Speaker 2>Yeah, you know that was certainly I would say the

0:05:11.156 --> 0:05:14.916
<v Speaker 2>general sort of I guess thinking at the time, right,

0:05:14.956 --> 0:05:17.236
<v Speaker 2>And you know, when we propose to do this, you know,

0:05:17.316 --> 0:05:19.956
<v Speaker 2>in my academic lab, we had a difficult time getting

0:05:19.956 --> 0:05:22.396
<v Speaker 2>funding for it, even at like a research level, because

0:05:22.436 --> 0:05:25.036
<v Speaker 2>the reviews would come back and say, this is you know,

0:05:25.196 --> 0:05:27.436
<v Speaker 2>this is impossible. There's no reason to even try to

0:05:27.476 --> 0:05:29.236
<v Speaker 2>do this because it will never work.

0:05:29.356 --> 0:05:32.316
<v Speaker 1>It's an engineering problem at a certain level at that point, right,

0:05:32.356 --> 0:05:34.876
<v Speaker 1>That is the sort of you have if you have

0:05:34.996 --> 0:05:38.276
<v Speaker 1>the genomic information, you know what genes you want, but

0:05:38.316 --> 0:05:39.836
<v Speaker 1>you got to figure out how to make them work

0:05:39.916 --> 0:05:44.116
<v Speaker 1>in a yeast, right, And I mean I want to

0:05:44.156 --> 0:05:46.116
<v Speaker 1>ask how do you do that? Although I know that's

0:05:46.156 --> 0:05:48.836
<v Speaker 1>like a ten year long answer, So maybe what I'll

0:05:48.836 --> 0:05:52.036
<v Speaker 1>ask instead is like, is there one piece of figuring

0:05:52.036 --> 0:05:55.876
<v Speaker 1>out how to do that that you can explain? You know,

0:05:56.036 --> 0:05:58.396
<v Speaker 1>is there one one thing you had to figure out

0:05:58.396 --> 0:06:00.356
<v Speaker 1>along the way where you came upon it and it

0:06:00.396 --> 0:06:03.276
<v Speaker 1>didn't work, and you figured out how to make it work.

0:06:04.116 --> 0:06:07.116
<v Speaker 2>Yeah, and you're right, this is an engineering problem. It's

0:06:07.116 --> 0:06:11.516
<v Speaker 2>a systems engineering problem. Right. So ultimately we're asking the

0:06:11.596 --> 0:06:15.316
<v Speaker 2>yeast to be this sort of mini nanofactory to produce

0:06:15.396 --> 0:06:19.156
<v Speaker 2>drug ingredients. Right, So not these sort of macro factories

0:06:19.196 --> 0:06:21.676
<v Speaker 2>we build out, you know, in our world, but really

0:06:21.716 --> 0:06:24.716
<v Speaker 2>kind of a cellular factory. So what's happening inside the cell.

0:06:25.036 --> 0:06:27.316
<v Speaker 2>One of the things that we brought to this field

0:06:27.436 --> 0:06:29.556
<v Speaker 2>is sort of a very unique strategy was to say,

0:06:30.316 --> 0:06:32.276
<v Speaker 2>you know, let's not the cell is not just a bag,

0:06:32.476 --> 0:06:34.956
<v Speaker 2>right where everything just sort of happens in this nebulous form.

0:06:35.036 --> 0:06:37.756
<v Speaker 2>Let's really think smartly about the cell as a system

0:06:38.076 --> 0:06:40.516
<v Speaker 2>and the biochemical environments that are in different locations of

0:06:40.516 --> 0:06:42.996
<v Speaker 2>the cell. And then when we change the sequence of

0:06:42.996 --> 0:06:45.996
<v Speaker 2>the proteins, we would very specifically give the yeast directions

0:06:46.036 --> 0:06:50.076
<v Speaker 2>of make this particular protein in this part of the

0:06:50.116 --> 0:06:53.156
<v Speaker 2>cell because there's a particular pH to do some environment,

0:06:53.196 --> 0:06:55.476
<v Speaker 2>you know. And then but this other part of you know,

0:06:55.476 --> 0:06:58.156
<v Speaker 2>the molecular machinery, the other steps of the proteins, we

0:06:58.196 --> 0:07:00.156
<v Speaker 2>want you to actually make it in this other area

0:07:00.156 --> 0:07:00.596
<v Speaker 2>of the cell.

0:07:00.956 --> 0:07:03.196
<v Speaker 1>So just to write to pick up on your factory metaphors.

0:07:03.236 --> 0:07:06.356
<v Speaker 1>So it's like the naive way to think about the

0:07:06.356 --> 0:07:08.916
<v Speaker 1>inside of the cell is just like a big empty room.

0:07:09.396 --> 0:07:11.756
<v Speaker 1>But you're thinking, like, no, it's not like that. I mean,

0:07:11.756 --> 0:07:13.476
<v Speaker 1>if the factory is the analogy, it's like, this part

0:07:13.476 --> 0:07:16.196
<v Speaker 1>over here is like where we should be whatever putting

0:07:16.236 --> 0:07:18.236
<v Speaker 1>the wheels on, and this part over here is clearly

0:07:18.236 --> 0:07:20.796
<v Speaker 1>where like the robot arms should be bolting the chassis together.

0:07:20.796 --> 0:07:24.676
<v Speaker 1>Because different parts of the inside of the cell are different,

0:07:24.756 --> 0:07:27.476
<v Speaker 1>are biochemically different, and some parts will work to do

0:07:27.876 --> 0:07:31.676
<v Speaker 1>some things and other parts will work to do other things,

0:07:31.676 --> 0:07:33.636
<v Speaker 1>and you can't do it in the wrong place or

0:07:33.676 --> 0:07:36.676
<v Speaker 1>it won't work exactly exactly.

0:07:36.676 --> 0:07:38.636
<v Speaker 2>I mean, that's an exact metaphor, right, and the exact

0:07:38.676 --> 0:07:39.756
<v Speaker 2>way to think about it, right.

0:07:40.116 --> 0:07:42.796
<v Speaker 1>And so let me ask just a few dumb questions

0:07:42.796 --> 0:07:44.796
<v Speaker 1>about that, because it's interesting. How do you tell the

0:07:44.836 --> 0:07:47.116
<v Speaker 1>cell where to do it?

0:07:47.116 --> 0:07:49.356
<v Speaker 2>It ultimately comes down to the directions you put in

0:07:49.356 --> 0:07:52.196
<v Speaker 2>the DNA, right, And it comes back to that gencoding

0:07:52.236 --> 0:07:55.356
<v Speaker 2>sequence where I mean, again it's biology does remarkable things,

0:07:55.436 --> 0:07:58.716
<v Speaker 2>but within you know, within that encoded sequence, you know

0:07:58.756 --> 0:08:02.316
<v Speaker 2>there are directions of you know, again exactly what amino acids.

0:08:02.356 --> 0:08:05.236
<v Speaker 2>You know, how you are basically making that protein amino

0:08:05.276 --> 0:08:08.316
<v Speaker 2>acid by amino acid. But there are also directions that

0:08:08.396 --> 0:08:12.116
<v Speaker 2>basically tell a cell and the cell's native machinery, no,

0:08:12.276 --> 0:08:14.076
<v Speaker 2>you're going to actually make the protein over in this

0:08:14.196 --> 0:08:16.596
<v Speaker 2>location right now. We want you to transport it over there.

0:08:16.636 --> 0:08:18.276
<v Speaker 2>We want you to move this over here, We want

0:08:18.276 --> 0:08:20.396
<v Speaker 2>you to insert it into this membrane. So you know,

0:08:20.396 --> 0:08:23.796
<v Speaker 2>I mean again, the cell is, it's so sophisticated, right,

0:08:24.476 --> 0:08:27.476
<v Speaker 2>we just you know, we just have to basically be

0:08:27.516 --> 0:08:31.116
<v Speaker 2>able to understand enough about the directions that the cell

0:08:31.236 --> 0:08:34.356
<v Speaker 2>uses and reads in its own native processes so that

0:08:34.396 --> 0:08:38.196
<v Speaker 2>we can begin to leverage you know, the strategies and

0:08:38.236 --> 0:08:40.836
<v Speaker 2>the routes that it has you know, developed, is a

0:08:40.836 --> 0:08:43.756
<v Speaker 2>way to move proteins to particular locations and cells.

0:08:44.036 --> 0:08:48.156
<v Speaker 1>So you figure that out over some period of time.

0:08:48.676 --> 0:08:52.516
<v Speaker 1>Is there a first drug ingredient that you get a

0:08:52.676 --> 0:08:55.516
<v Speaker 1>Y cell to make? Is there some like proof of

0:08:55.636 --> 0:08:56.556
<v Speaker 1>concept moment?

0:08:57.396 --> 0:09:00.876
<v Speaker 2>Yeah? There, yes, there was. So the drug ingredient that

0:09:00.916 --> 0:09:05.116
<v Speaker 2>we initially demonstrated with this is an ingredient called the

0:09:05.236 --> 0:09:09.036
<v Speaker 2>dane And this is actually an ingredient that is extracted

0:09:09.116 --> 0:09:11.556
<v Speaker 2>from medicinal plants, and it's an ingredient that's used to

0:09:11.556 --> 0:09:15.956
<v Speaker 2>produce about half a dozen different drug ingredients, from drugs

0:09:15.996 --> 0:09:19.316
<v Speaker 2>that are used to treat you very severe pain, to

0:09:19.476 --> 0:09:23.516
<v Speaker 2>drugs that are used as rescue mediations to treat addiction

0:09:24.476 --> 0:09:26.956
<v Speaker 2>and as well as overdose.

0:09:27.436 --> 0:09:29.636
<v Speaker 1>Like the drug that has the brand name Narcan. Is

0:09:29.636 --> 0:09:30.876
<v Speaker 1>it not lots like that?

0:09:30.956 --> 0:09:31.076
<v Speaker 2>Oh?

0:09:31.196 --> 0:09:31.596
<v Speaker 1>Interesting?

0:09:31.796 --> 0:09:35.996
<v Speaker 2>Is that drug Narcan and naloxone is a drug that

0:09:36.116 --> 0:09:39.476
<v Speaker 2>is used that is basically produced from the vein. We

0:09:39.556 --> 0:09:43.396
<v Speaker 2>published that demonstration, that proof of principal demonstration in twenty fifteen,

0:09:43.956 --> 0:09:46.036
<v Speaker 2>so that was and again that was done prior to

0:09:46.076 --> 0:09:49.276
<v Speaker 2>us starting anthea. It was done in our the academic

0:09:49.316 --> 0:09:54.436
<v Speaker 2>lab at Stanford, and again that particular demonstration, it took

0:09:54.436 --> 0:09:57.636
<v Speaker 2>over a decade, right to bring it all together. So

0:09:57.676 --> 0:09:59.476
<v Speaker 2>it was a very long term project in my lab

0:09:59.876 --> 0:10:01.876
<v Speaker 2>for the very reasons that we discussed for all of

0:10:01.876 --> 0:10:05.716
<v Speaker 2>these challenges, right, and it was one that because I

0:10:05.716 --> 0:10:08.036
<v Speaker 2>would say the field in general viewed it to be

0:10:08.076 --> 0:10:11.716
<v Speaker 2>impossible and thus not worth you know, spending research dollars on.

0:10:11.756 --> 0:10:12.956
<v Speaker 2>It was one that we spent a lot of time

0:10:12.956 --> 0:10:15.236
<v Speaker 2>bootstrapping in my lab because I really had a lot

0:10:15.236 --> 0:10:16.876
<v Speaker 2>of conviction that we could get this done.

0:10:16.996 --> 0:10:20.796
<v Speaker 1>So you publish this paper to show that you can

0:10:21.436 --> 0:10:26.716
<v Speaker 1>get yeased to produce this drug ingredient. What happens next?

0:10:26.956 --> 0:10:29.756
<v Speaker 2>The next questions are can it be done at an

0:10:29.756 --> 0:10:34.076
<v Speaker 2>efficiency and scale such that this can really offer you know,

0:10:34.156 --> 0:10:37.756
<v Speaker 2>solutions right to the industry, Because if you take what

0:10:37.796 --> 0:10:40.396
<v Speaker 2>we showed in twenty fifteen tried to scale it up,

0:10:40.676 --> 0:10:42.396
<v Speaker 2>I mean you would it would not be offering a

0:10:42.396 --> 0:10:46.436
<v Speaker 2>solution because it was so inefficient. Is still not efficiently

0:10:46.476 --> 0:10:50.836
<v Speaker 2>converting the sugar to that drug ingredient such that it

0:10:50.836 --> 0:10:53.276
<v Speaker 2>would just be too expensive because ultimately price is a

0:10:53.276 --> 0:10:56.036
<v Speaker 2>big consideration. So you know, there were and just to

0:10:56.076 --> 0:10:58.596
<v Speaker 2>give you like a sense of the degree what we're

0:10:58.596 --> 0:11:02.356
<v Speaker 2>discussing here, right again, when we look at what was

0:11:02.356 --> 0:11:04.996
<v Speaker 2>demonstrated in twenty fifteen, you know the yest we're producing

0:11:05.116 --> 0:11:08.676
<v Speaker 2>very low concentrations of that drug ingredient. We at Inthea

0:11:08.716 --> 0:11:11.956
<v Speaker 2>had to optimize that by over a millionfold, and not

0:11:12.036 --> 0:11:15.676
<v Speaker 2>just in scale but in efficiency of converting. That had

0:11:15.716 --> 0:11:19.956
<v Speaker 2>to be able to produce a million times higher concentration

0:11:20.636 --> 0:11:23.556
<v Speaker 2>of that drug ingredient than what we demonstrated.

0:11:23.076 --> 0:11:25.916
<v Speaker 1>A million times more drug per unit.

0:11:25.676 --> 0:11:28.796
<v Speaker 2>Sugar exactly right, or per unit use really right, So.

0:11:28.796 --> 0:11:31.556
<v Speaker 1>The yeast has to get way, way way better. Sure

0:11:31.556 --> 0:11:34.076
<v Speaker 1>it can make the drug. It's really bad at making

0:11:34.076 --> 0:11:38.636
<v Speaker 1>the drug. In two, it's terrible at making it exactly.

0:11:38.796 --> 0:11:41.236
<v Speaker 2>That's sort of independent of scale, you know, in terms

0:11:41.236 --> 0:11:43.716
<v Speaker 2>of like the volume that you're producing. It's saying, okay,

0:11:43.916 --> 0:11:45.716
<v Speaker 2>you know, whether you're we're growing you at a mill

0:11:45.756 --> 0:11:47.916
<v Speaker 2>or we're growing you at you know, one hundred thousand liters,

0:11:48.196 --> 0:11:50.396
<v Speaker 2>we need you to really steff up your game.

0:11:50.636 --> 0:11:52.476
<v Speaker 1>And yeah, right, you.

0:11:52.396 --> 0:11:54.756
<v Speaker 2>Know, converting that sugar into the drug product. And so

0:11:55.356 --> 0:11:59.036
<v Speaker 2>again that comes back to a lot it's an engineering problem.

0:11:59.076 --> 0:12:01.476
<v Speaker 1>So okay, this is the next problem you have what

0:12:01.636 --> 0:12:02.996
<v Speaker 1>you know, what what are some of the things you

0:12:03.036 --> 0:12:04.476
<v Speaker 1>do to increase efficiency.

0:12:04.716 --> 0:12:06.636
<v Speaker 2>So you know, again if we come back to this

0:12:06.756 --> 0:12:09.596
<v Speaker 2>idea of you know, you're assembling a car and a factory,

0:12:09.676 --> 0:12:11.796
<v Speaker 2>right and it's going through these different lines to sort

0:12:11.836 --> 0:12:14.156
<v Speaker 2>of build it in a modular way. That's you know,

0:12:14.316 --> 0:12:17.356
<v Speaker 2>the sort of manufacturing assembly line that you've developed is

0:12:17.356 --> 0:12:19.796
<v Speaker 2>sort of where you want your your drug ingredient to

0:12:19.836 --> 0:12:23.156
<v Speaker 2>stay on track, right, But it is operating within this

0:12:23.196 --> 0:12:26.196
<v Speaker 2>more broader complex system of the yeast. And so the

0:12:26.276 --> 0:12:29.916
<v Speaker 2>yeast will have just natural processes that it's developed, and

0:12:29.996 --> 0:12:32.396
<v Speaker 2>some of those will actually begin to interface with the

0:12:32.436 --> 0:12:34.876
<v Speaker 2>assembly line that you've put in, and so it.

0:12:34.796 --> 0:12:37.796
<v Speaker 1>Can start the yeast is busy being a yeast cell, right,

0:12:37.836 --> 0:12:41.556
<v Speaker 1>Like the yeast was not born to make this drug ingredient.

0:12:41.796 --> 0:12:43.636
<v Speaker 2>And it's you know, it's busy, as you say, being

0:12:43.636 --> 0:12:45.476
<v Speaker 2>in a e cell. It has its own objectives that

0:12:45.516 --> 0:12:48.836
<v Speaker 2>it wants to achieve, right in terms of you know, growing,

0:12:49.036 --> 0:12:52.996
<v Speaker 2>you know, doubling, and you know, producing its own products. Yeah,

0:12:53.156 --> 0:12:55.036
<v Speaker 2>it has its own dreams and you know, things that

0:12:55.076 --> 0:12:57.676
<v Speaker 2>it wants to accomplish. And so it's you know, the

0:12:57.756 --> 0:13:01.316
<v Speaker 2>natural system that you put it within is basically interfacing

0:13:01.436 --> 0:13:03.116
<v Speaker 2>with that assembly line that you've put it in. And

0:13:03.156 --> 0:13:07.876
<v Speaker 2>in many cases, right those natural systems can actually pull

0:13:07.916 --> 0:13:11.476
<v Speaker 2>away or divert your drug ingredient from the desired endpoint,

0:13:12.236 --> 0:13:14.276
<v Speaker 2>just you know, because of these interactions.

0:13:14.316 --> 0:13:16.876
<v Speaker 1>That's the weird thing, Like the yeast is making you crazy,

0:13:16.916 --> 0:13:19.796
<v Speaker 1>but like the yeast is also like the thing that's

0:13:19.796 --> 0:13:22.436
<v Speaker 1>making the thing you need exactly right, and so you have.

0:13:22.516 --> 0:13:25.556
<v Speaker 2>To really balance that very carefully because and so I mean,

0:13:25.596 --> 0:13:28.476
<v Speaker 2>you want the use to be multiplying, because every time

0:13:28.476 --> 0:13:31.156
<v Speaker 2>it multiplies, it's providing another cell factory that's going to

0:13:31.156 --> 0:13:34.236
<v Speaker 2>reduce drug ingredients. So you it's this balance between allowing

0:13:34.276 --> 0:13:36.596
<v Speaker 2>the EAST to obtain its objectives, which also feed into

0:13:36.596 --> 0:13:39.476
<v Speaker 2>your objectives, but then where it is, you know, being

0:13:39.516 --> 0:13:42.956
<v Speaker 2>disruptive to your process, trying to make surgical changes that

0:13:42.996 --> 0:13:45.676
<v Speaker 2>will still allow the yeast to be relatively happy, you know,

0:13:45.716 --> 0:13:47.516
<v Speaker 2>and feel like it is doing what it needs to do,

0:13:47.596 --> 0:13:49.916
<v Speaker 2>but still but then allowing more of your drug ingredient

0:13:49.956 --> 0:13:52.196
<v Speaker 2>to grow, to go towards the product that you ultimately

0:13:52.236 --> 0:13:52.796
<v Speaker 2>want to produce.

0:13:57.036 --> 0:13:59.116
<v Speaker 1>A few weeks ago and they announced that they had

0:13:59.156 --> 0:14:03.156
<v Speaker 1>completed their first manufacturing scale production of the bay and

0:14:03.236 --> 0:14:05.876
<v Speaker 1>they plan to start selling the ingredient to drug makers

0:14:06.036 --> 0:14:19.116
<v Speaker 1>next year. We'll be back in a minute. Now, back

0:14:19.156 --> 0:14:24.476
<v Speaker 1>to the show. So let's talk about drug shortages. To me,

0:14:24.676 --> 0:14:29.116
<v Speaker 1>still somewhat strange phenomenon in the United States, a country

0:14:29.156 --> 0:14:31.356
<v Speaker 1>where we're a rich country and we spend tons of

0:14:31.356 --> 0:14:33.356
<v Speaker 1>money on drugs, although no generic drugs are cheap, and

0:14:33.356 --> 0:14:34.796
<v Speaker 1>that's part of the thing. We can talk about that,

0:14:35.076 --> 0:14:41.756
<v Speaker 1>but it is remarkable how widespread and persistent drug shortages

0:14:41.796 --> 0:14:44.716
<v Speaker 1>are shortages in particular of generic drugs, and they seem

0:14:44.716 --> 0:14:48.676
<v Speaker 1>to be increasing over the last few years. What's going

0:14:48.716 --> 0:14:49.156
<v Speaker 1>on there?

0:14:49.716 --> 0:14:51.396
<v Speaker 2>I mean, I think one thing that has been noted

0:14:51.476 --> 0:14:53.916
<v Speaker 2>and that is notable is that in the US we

0:14:54.036 --> 0:14:58.596
<v Speaker 2>do not have manufacturing capacity to produce drug ingredients or

0:14:58.676 --> 0:15:01.476
<v Speaker 2>drug products really, right, It's very limited. Most of the

0:15:01.516 --> 0:15:04.076
<v Speaker 2>drugs that we consume are basically produced outside of the

0:15:04.196 --> 0:15:07.676
<v Speaker 2>US about ninety percent. What that ultimately plays into quite

0:15:07.676 --> 0:15:10.916
<v Speaker 2>a bit is lack of transparency and control over these

0:15:10.916 --> 0:15:14.676
<v Speaker 2>supply chains, right, because we don't have any domestic capacity.

0:15:14.996 --> 0:15:18.316
<v Speaker 2>Because the supply chains actually are quite complex in terms

0:15:18.356 --> 0:15:21.036
<v Speaker 2>of the different players involved, oftentimes we don't have a

0:15:21.036 --> 0:15:25.396
<v Speaker 2>lot of notice or yeah, really notice or transparency into

0:15:25.476 --> 0:15:27.236
<v Speaker 2>if we expect that there's going to be an issue

0:15:27.236 --> 0:15:30.436
<v Speaker 2>with the supply chain. Right, there's just again very limited transparency.

0:15:30.476 --> 0:15:33.196
<v Speaker 2>It's very difficult to track through all the supply chains. Now,

0:15:33.596 --> 0:15:37.476
<v Speaker 2>when you talk about just manufacturing technology for drugs and

0:15:37.516 --> 0:15:40.476
<v Speaker 2>the ways that they're being manufactured, there's essentially two different

0:15:40.516 --> 0:15:43.356
<v Speaker 2>ways that all of our drugs are being produced. Right.

0:15:43.636 --> 0:15:46.836
<v Speaker 2>We talked about agricultural sourcing, which a lot of that

0:15:46.916 --> 0:15:49.756
<v Speaker 2>is sort of where we focus. But again about forty

0:15:49.756 --> 0:15:52.796
<v Speaker 2>percent of our drugs are being produced through agricultural sourcing.

0:15:52.916 --> 0:15:57.436
<v Speaker 2>These are very complex basically drug ingredients. We cannot produce

0:15:57.436 --> 0:16:00.236
<v Speaker 2>them at scale with chemical synthesis, and so we still

0:16:00.276 --> 0:16:02.916
<v Speaker 2>basically rely on biological synthesis to produce them.

0:16:03.076 --> 0:16:05.556
<v Speaker 1>To be clear, you mean they come from plants.

0:16:05.476 --> 0:16:09.956
<v Speaker 2>Plants, sometimes other animals, right, So you know there are

0:16:10.436 --> 0:16:13.396
<v Speaker 2>in drug ingredients that are a extracted from animals or

0:16:13.436 --> 0:16:16.036
<v Speaker 2>even you know, sometimes it could be rare marine coral.

0:16:16.116 --> 0:16:17.716
<v Speaker 2>I mean, you know, but so you do really get

0:16:17.716 --> 0:16:19.156
<v Speaker 2>a spectrum. I think the bulk of it is going

0:16:19.196 --> 0:16:21.436
<v Speaker 2>to be plants, but it will meld into other areas.

0:16:22.036 --> 0:16:24.636
<v Speaker 2>But all of these you can imagine, these supply chains

0:16:24.636 --> 0:16:28.276
<v Speaker 2>are increasingly vulnerable. If you're farming in a small number

0:16:28.396 --> 0:16:30.476
<v Speaker 2>of areas across the globe and you have a fire

0:16:30.556 --> 0:16:32.876
<v Speaker 2>that goes through a region, or a flood, or you know,

0:16:32.996 --> 0:16:36.476
<v Speaker 2>any one of the sort of climate catastrophes we're sort

0:16:36.476 --> 0:16:38.636
<v Speaker 2>of seen and out of increasing frequency that can really

0:16:38.676 --> 0:16:42.916
<v Speaker 2>wipe out basically the crops and a large fraction of

0:16:43.116 --> 0:16:46.116
<v Speaker 2>the material that's being produced in any given year. And

0:16:46.196 --> 0:16:50.036
<v Speaker 2>so there can have these variabilities, right, also variabilities in

0:16:50.076 --> 0:16:52.916
<v Speaker 2>farming practices, variability and pest and disease that go through

0:16:52.916 --> 0:16:54.716
<v Speaker 2>an area. The point is that there's a lot of

0:16:54.796 --> 0:16:58.956
<v Speaker 2>vulnerability and variability that is becoming increasingly difficult to predict

0:16:58.996 --> 0:17:01.996
<v Speaker 2>and also just increasing in frequency. So what that means

0:17:02.076 --> 0:17:04.436
<v Speaker 2>is that supplies can vary right from year to year,

0:17:04.476 --> 0:17:06.436
<v Speaker 2>from growing season to growing season. And the other thing

0:17:06.516 --> 0:17:09.676
<v Speaker 2>is because the manufacturing cycles are so long, you know,

0:17:09.756 --> 0:17:11.756
<v Speaker 2>any one of these because of the time it takes

0:17:11.796 --> 0:17:15.076
<v Speaker 2>to grow the biomass or the organism right to complete

0:17:15.076 --> 0:17:17.876
<v Speaker 2>a manufacturing cycle. For most medicinal plants, it can be

0:17:17.996 --> 0:17:21.316
<v Speaker 2>two years to sometimes five years, right, just because of

0:17:21.356 --> 0:17:23.796
<v Speaker 2>how slow they might grow. So if you wipe out

0:17:24.396 --> 0:17:26.396
<v Speaker 2>a crop for any given growing season, you don't have

0:17:26.436 --> 0:17:30.116
<v Speaker 2>the ability to just grow more, right, you have to replant,

0:17:30.156 --> 0:17:32.996
<v Speaker 2>receive That can take years, So there's no ability to

0:17:32.996 --> 0:17:37.156
<v Speaker 2>sort of respond rapidly if demand changes or if you know,

0:17:37.276 --> 0:17:41.076
<v Speaker 2>part of your supply chain basically goes down with fermentation.

0:17:41.516 --> 0:17:45.516
<v Speaker 2>Right now, what you have is very sort of consistent infrastructure.

0:17:45.516 --> 0:17:49.756
<v Speaker 2>It's basically a fermentation vat whether you're producing a chemotherapeutic,

0:17:50.116 --> 0:17:54.596
<v Speaker 2>a sedative and anti infective right, or a pain medication.

0:17:55.156 --> 0:17:59.156
<v Speaker 2>Regardless of what ingredient you're producing, the infrastructure is the same.

0:17:59.276 --> 0:18:02.436
<v Speaker 2>You're basically swapping in different strains of yeast, and the

0:18:02.436 --> 0:18:05.476
<v Speaker 2>manufacturing cycle time is so fast, right, It's basically two

0:18:05.476 --> 0:18:08.796
<v Speaker 2>weeks a week to grow the yeast, get the drug produced,

0:18:08.796 --> 0:18:10.836
<v Speaker 2>and then an other several days to purify it to

0:18:10.916 --> 0:18:14.516
<v Speaker 2>really pure form. So because of the fast manufacturing cycle time,

0:18:14.956 --> 0:18:19.356
<v Speaker 2>and then because the infrastructure is very readily repurposable, right,

0:18:19.356 --> 0:18:22.996
<v Speaker 2>because ultimately it's the same, you can and you can

0:18:23.036 --> 0:18:26.756
<v Speaker 2>actually switch a facility from producing a chemotherapeutic to producing

0:18:26.796 --> 0:18:28.556
<v Speaker 2>a sedative in a matter of two days.

0:18:28.876 --> 0:18:31.396
<v Speaker 1>So the dream is to be the swing supply or

0:18:31.396 --> 0:18:34.036
<v Speaker 1>for whatever ingredient is in short supply in a way

0:18:34.076 --> 0:18:37.556
<v Speaker 1>that people who are using traditional technologies cannot be because

0:18:37.556 --> 0:18:39.116
<v Speaker 1>of the nature of the technology.

0:18:39.836 --> 0:18:41.316
<v Speaker 2>Yeah, I mean, I would let me just say, I

0:18:41.316 --> 0:18:44.316
<v Speaker 2>think I think for for me, the dream is actually

0:18:44.316 --> 0:18:46.836
<v Speaker 2>to disrupt the market, right, I mean, we shouldn't be

0:18:46.916 --> 0:18:51.476
<v Speaker 2>farming drug ingredients. It's very wasteful from a resource perspective

0:18:51.796 --> 0:18:54.156
<v Speaker 2>that land can be used to produce food, right, and

0:18:54.276 --> 0:18:58.236
<v Speaker 2>other products that you know we need for a growing population, right,

0:18:58.276 --> 0:19:00.556
<v Speaker 2>you waste a lot of biomass. You waste a lot

0:19:00.596 --> 0:19:02.596
<v Speaker 2>of water, I mean other things because most of that

0:19:02.636 --> 0:19:05.676
<v Speaker 2>plant material you're basically throwing away. It's just not a

0:19:05.676 --> 0:19:08.796
<v Speaker 2>good use of resources. So really the dream is this

0:19:08.796 --> 0:19:12.596
<v Speaker 2>techno should disrupt and transform the industry. It just makes

0:19:12.636 --> 0:19:16.716
<v Speaker 2>more sense, right. It can actually provide these ingredients at

0:19:16.716 --> 0:19:19.996
<v Speaker 2>a cheaper cost, It could provide them at a more consistent,

0:19:20.436 --> 0:19:23.396
<v Speaker 2>better quality, right, And it's it's just a more efficient

0:19:23.476 --> 0:19:26.156
<v Speaker 2>use of resources. So it really should be that transformation

0:19:26.196 --> 0:19:26.836
<v Speaker 2>in the industry.

0:19:30.516 --> 0:19:32.796
<v Speaker 1>We'll be back in a minute with the lightning round.

0:19:43.556 --> 0:19:45.516
<v Speaker 1>Back to the show. We just have to do a

0:19:45.556 --> 0:19:48.276
<v Speaker 1>lightning round, and then you can go. As a professor

0:19:48.276 --> 0:19:53.196
<v Speaker 1>of bioengineering, what do you understand about biology and or

0:19:53.276 --> 0:19:56.436
<v Speaker 1>engineering that most people don't understand?

0:19:56.876 --> 0:20:01.676
<v Speaker 2>I think you know. One thing is as engineers, we

0:20:01.796 --> 0:20:05.916
<v Speaker 2>provide solutions. We develop solutions with imperfect data, right, and

0:20:05.996 --> 0:20:08.276
<v Speaker 2>imperfect knowledge of the system. We have to have enough

0:20:08.316 --> 0:20:10.916
<v Speaker 2>knowledge and enough day to provide solutions that are going

0:20:10.956 --> 0:20:13.196
<v Speaker 2>to be meaningful, that are going to scale, right. But

0:20:13.396 --> 0:20:16.996
<v Speaker 2>and I think that can be at odds with a biologist, right,

0:20:17.076 --> 0:20:19.076
<v Speaker 2>or someone who's studying the pure science where we really

0:20:19.116 --> 0:20:22.036
<v Speaker 2>want to understand all the nuance, you know, understand everything

0:20:22.036 --> 0:20:24.156
<v Speaker 2>in sort of the beautiful detailed intricacy.

0:20:24.276 --> 0:20:25.796
<v Speaker 1>What's your favorite yeast?

0:20:26.516 --> 0:20:32.116
<v Speaker 2>Yeah, I really do like sacrimicos seravisier and you.

0:20:32.076 --> 0:20:33.916
<v Speaker 1>Know, tell me about sacrimisis.

0:20:34.156 --> 0:20:37.076
<v Speaker 2>Well, it's a it's a strain of use that we

0:20:37.156 --> 0:20:39.076
<v Speaker 2>use at anthea, but it's also the strain of right,

0:20:39.076 --> 0:20:41.916
<v Speaker 2>it's also use that are used again as brewers use

0:20:41.996 --> 0:20:42.796
<v Speaker 2>you know Baker's uast.

0:20:42.916 --> 0:20:45.396
<v Speaker 1>Right, if you weren't working on drug ingredients, what would

0:20:45.396 --> 0:20:45.956
<v Speaker 1>you be working on?

0:20:49.236 --> 0:20:51.996
<v Speaker 2>It's a good question. There's there's different ways to take that.

0:20:52.076 --> 0:20:54.436
<v Speaker 2>I mean, I think that there are a lot of

0:20:55.076 --> 0:20:58.396
<v Speaker 2>problems that are important in the context of synthetic biology.

0:20:59.476 --> 0:21:02.636
<v Speaker 2>You know, I could also I would love to also

0:21:02.996 --> 0:21:04.716
<v Speaker 2>there's another part of my life and sort of a

0:21:04.756 --> 0:21:06.276
<v Speaker 2>second life that I might live where I'm in a

0:21:06.356 --> 0:21:10.396
<v Speaker 2>very different industry. Right, So you know, but that that

0:21:10.436 --> 0:21:12.276
<v Speaker 2>did not that is not the road that we took.

0:21:12.796 --> 0:21:14.796
<v Speaker 1>What like, I feel like there's a very particular thing

0:21:14.836 --> 0:21:17.516
<v Speaker 1>in your mind as you say that, what is that? No? No, no,

0:21:17.556 --> 0:21:20.716
<v Speaker 1>I mean I you're thinking of something. What is the

0:21:20.716 --> 0:21:23.196
<v Speaker 1>thing I always.

0:21:22.916 --> 0:21:25.916
<v Speaker 2>I always joke with my friends and I would love

0:21:25.956 --> 0:21:28.436
<v Speaker 2>to just you know, my retirement plan on basically after

0:21:28.516 --> 0:21:31.196
<v Speaker 2>all of this is to go be like, I don't know,

0:21:31.356 --> 0:21:35.476
<v Speaker 2>an assistant to someone like Wes Anderson who makes these

0:21:35.476 --> 0:21:39.916
<v Speaker 2>incredible films that you know, I adore and I feel,

0:21:39.996 --> 0:21:42.596
<v Speaker 2>you know, and and really just create these very interesting worlds,

0:21:42.596 --> 0:21:44.556
<v Speaker 2>and I feel like I just would want to, you know,

0:21:44.596 --> 0:21:46.396
<v Speaker 2>maybe get his coffee or something.

0:21:46.516 --> 0:21:48.876
<v Speaker 1>Do you think of going into the movies when you

0:21:48.916 --> 0:21:50.636
<v Speaker 1>were whatever in college or something?

0:21:50.676 --> 0:21:52.876
<v Speaker 2>I mean in high school, I actually spent all my

0:21:52.916 --> 0:21:56.516
<v Speaker 2>time in drama, right, basically you know, doing school plays,

0:21:56.556 --> 0:21:58.996
<v Speaker 2>doing musicals, I mean, all that stuff. So and I

0:21:59.036 --> 0:22:00.996
<v Speaker 2>really thought up until the point of I was making

0:22:01.036 --> 0:22:04.676
<v Speaker 2>decisions to apply to college, you know, I thought that

0:22:04.676 --> 0:22:08.236
<v Speaker 2>I would go into basically theater and you know, do theater,

0:22:08.396 --> 0:22:11.036
<v Speaker 2>do movies, whatever. And then I just, you know, as

0:22:11.076 --> 0:22:15.916
<v Speaker 2>I was actually applying, kind of had a revelation of

0:22:16.156 --> 0:22:17.636
<v Speaker 2>do I really want to do that, you know, for

0:22:17.676 --> 0:22:20.596
<v Speaker 2>the rest of my life? It actually seemed difficult. Not

0:22:20.636 --> 0:22:22.436
<v Speaker 2>that what we're doing now isn't difficult, but it seemed

0:22:22.436 --> 0:22:25.316
<v Speaker 2>difficult in a way that maybe was difficult. You know,

0:22:25.396 --> 0:22:27.316
<v Speaker 2>even as much work as I could put in, right,

0:22:27.396 --> 0:22:30.316
<v Speaker 2>it's it's not necessarily you can't necessarily project the outcome,

0:22:30.676 --> 0:22:32.756
<v Speaker 2>and even at that time, you know, it was sort

0:22:32.796 --> 0:22:35.036
<v Speaker 2>of taking a step back and saying, you know, what

0:22:35.076 --> 0:22:36.476
<v Speaker 2>can I do? What do I want to do? Which

0:22:36.476 --> 0:22:39.316
<v Speaker 2>allows me to sort of build create, you know, and

0:22:39.756 --> 0:22:42.356
<v Speaker 2>make things and produce things, but something that could really

0:22:42.356 --> 0:22:45.556
<v Speaker 2>have a meaningful impact right on the world. And so

0:22:45.636 --> 0:22:48.676
<v Speaker 2>that kind of that then led me to engineering, you know,

0:22:48.836 --> 0:22:51.796
<v Speaker 2>engineering with biology and and and really that sort of

0:22:51.836 --> 0:22:53.676
<v Speaker 2>started that route as I went into college.

0:22:54.596 --> 0:22:57.316
<v Speaker 1>I've taken up enough of your time. Is there anything

0:22:57.356 --> 0:22:58.156
<v Speaker 1>else you want to say?

0:22:59.756 --> 0:23:02.036
<v Speaker 2>No, I think you've done a great job of directing

0:23:02.076 --> 0:23:05.676
<v Speaker 2>the conversation. So hopefully it's you know, then at a

0:23:05.676 --> 0:23:07.276
<v Speaker 2>good level for the Are.

0:23:07.156 --> 0:23:09.116
<v Speaker 1>They not at all worried? Sometimes at the end of inner,

0:23:09.436 --> 0:23:10.756
<v Speaker 1>I'm like, how am I going to make this work? Guy?

0:23:10.796 --> 0:23:12.356
<v Speaker 1>This is gonna be an easy one. This is great.

0:23:12.436 --> 0:23:14.756
<v Speaker 2>Thank you, absolutely, thank you.

0:23:20.876 --> 0:23:24.436
<v Speaker 1>Christina Smolke is the co founder and CEO of Anthea.

0:23:25.796 --> 0:23:29.956
<v Speaker 1>Today's show was edited by Karen Chakerjee, produced by Edith Russolo,

0:23:30.116 --> 0:23:31.676
<v Speaker 1>and engineered by Amanda K.

0:23:32.036 --> 0:23:32.316
<v Speaker 2>Wall.

0:23:33.596 --> 0:23:36.436
<v Speaker 1>You can email us at problem at pushkin dot fm.

0:23:36.476 --> 0:23:40.316
<v Speaker 1>We are always, always, always trying to find interesting new

0:23:40.356 --> 0:23:42.276
<v Speaker 1>guests for the show, So if there's somebody who think

0:23:42.276 --> 0:23:45.236
<v Speaker 1>we should book, please let us know. I'm Jacob Goldstein

0:23:45.276 --> 0:23:47.476
<v Speaker 1>and we'll be back next week with another episode of

0:23:47.516 --> 0:23:52.916
<v Speaker 1>What's Your Problem.